---

---

entities : Gilead sciences, inc.   

save search

---

Vir Biotechnology Appoints Sung Lee as Chief Financial Officer
Published: 2023-02-16 (Crawled : 14:00) - globenewswire.com
VIR | $8.04 -1.11% -1.12% 770K |

Health Technology

| -69.91% | O: -1.65% H: 0.3% C: -2.7%
SGMO | News | $0.493 -5.36% -6.07% 1.2M |

Health Technology

| -83.67% | O: 0.0% H: 2.5% C: -1.0%
MOR | News | $18.05 0.06% 0.17% 130K |

Health Technology

| 261.72% | O: -2.4% H: 1.23% C: -1.44%
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -21.13% | O: -0.87% H: 0.53% C: -1.09%
financial

---

THE ELIZABETH TAYLOR AIDS FOUNDATION AND THE HIV IS NOT A CRIME CAMPAIGN WIN BIG AT THE ANTHEM AWARDS
Published: 2023-02-15 (Crawled : 22:00) - prnewswire.com
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -21.13% | O: -0.87% H: 0.53% C: -1.09%
awards hiv

---

Schrödinger Receives $111.3 Million Distribution from Sale of Nimbus’s TYK2 Inhibitor to Takeda
Published: 2023-02-14 (Crawled : 16:00) - biospace.com/
SDGR | $24.04 -3.1% -3.2% 570K |

Technology Services

| 4.89% | O: -1.66% H: 8.12% C: 7.28%
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -23.33% | O: 0.11% H: 0.02% C: -2.18%
distribution

---

Gilead Demonstrates Transformative Potential Impact Of Antiviral Innovation at CROI 2023
Published: 2023-02-14 (Crawled : 14:00) - biospace.com/
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -23.33% | O: 0.11% H: 0.02% C: -2.18%
antiviral impact potential innovation

---

Kite’s Tecartus® CAR T-Cell Therapy Demonstrates Overall Survival Benefit in Three-Year Follow-up of Pivotal ZUMA-3 Trial in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Published: 2023-02-09 (Crawled : 13:00) - biospace.com/
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -21.7% | O: 0.19% H: 0.9% C: -0.35%
tecartus t-cell leukemia trial therapy

---

Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease
Published: 2023-02-08 (Crawled : 00:00) - globenewswire.com
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -21.7% | O: 0.19% H: 0.9% C: -0.35%
GLPG | News | $28.77 -2.31% -2.33% 130K |

Health Technology

| -33.98% | O: -8.03% H: 0.95% C: 0.75%
disease topline trial results

---

2023 CALIFORNIA CONFERENCE FOR WOMEN TO FOCUS ON LEADERSHIP, CONNECTION, AND BEING A FORCE FOR CHANGE
Published: 2023-02-08 (Crawled : 21:00) - prnewswire.com
STT 4 | $74.29 -0.13% 0.0% 8.6M |

Finance

| -20.62% | O: 0.21% H: 0.74% C: -1.34%
JNPR | $35.36 -1.45% 1.36% 4.7M |

Technology Services

| 13.84% | O: 0.87% H: 0.22% C: -1.15%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -9.46% | O: 0.01% H: 0.71% C: -1.36%
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -21.7% | O: 0.19% H: 0.9% C: -0.35%
california conference women change

---

U.S. FDA Approves Trodelvy® in Pre-treated HR+/HER2- Metastatic Breast Cancer
Published: 2023-02-03 (Crawled : 19:00) - biospace.com/
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -17.58% | O: 4.01% H: 2.73% C: -0.18%
trodelvy fda breast cancer her2 metastatic breast cancer

---

Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-02-02 (Crawled : 23:00) - biospace.com/
ACLX | $52.82 -2.98% -3.12% 310K |

| 62.02% | O: 0.15% H: 2.24% C: 2.21%
RCUS 4 | $15.43 -0.45% 0.0% 520K |

Health Technology

| -31.02% | O: -6.12% H: 4.9% C: 0.76%
MGNX | $15.7 -3.27% -3.38% 520K |

Health Technology

| 163.87% | O: -0.5% H: 2.87% C: 0.0%
JNCE | $1.88 -2.59% -1.85% 0 |

Health Technology

| 60.5% | O: 3.36% H: 2.44% C: -1.63%
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -20.14% | O: -1.95% H: 0.16% C: -1.18%
sciences year financial results

---

The Global Antiviral Drugs Market to Exhibit Growth at a Paltry CAGR of ~4% by 2027 | DelveInsight
Published: 2023-02-02 (Crawled : 16:00) - prnewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 31.55% | O: -1.71% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 4.4M |

Health Technology

| -5.79% | O: -0.16% H: 0.08% C: -0.41%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 11.47% | O: -1.87% H: 0.01% C: -0.55%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -10.17% | O: -1.16% H: 1.98% C: 1.56%
BMY | $48.86 -0.27% 1.0% 14M |

Health Technology

| -31.41% | O: -1.28% H: 3.64% C: 3.48%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 14.46% | O: -0.46% H: 0.0% C: -0.75%
VIR | $8.04 -1.11% -1.12% 770K |

Health Technology

| -72.43% | O: 0.62% H: 2.22% C: 1.94%
TNXP | $0.16 2.04% 1.2% 940K |

Health Technology

| -97.81% | O: 0.85% H: 5.08% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -2.28% | O: -1.44% H: 0.0% C: 0.0%
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -20.14% | O: -1.95% H: 0.16% C: -1.18%
global antiviral growth market

---

Gilead Awards $7.6 Million in Grants to Advance Health Equity in Breast Cancer
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -20.09% | O: 0.08% H: 0.77% C: -0.01%
awards breast health grants cancer

---

Kite and Arcellx Close Agreement to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma
Published: 2023-01-30 (Crawled : 15:20) - biospace.com/
ACLX | $52.82 -2.98% -3.12% 310K |

| 55.63% | O: -0.09% H: 3.69% C: -3.16%
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -19.89% | O: -0.25% H: 0.38% C: -0.2%
agreement

---

SK bioscience Appoints New Executives to Accelerate New Growth Strategies
Published: 2023-01-20 (Crawled : 12:20) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -5.69% | O: -2.08% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -3.76% | O: -0.41% H: 0.0% C: 0.0%
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -19.78% | O: -0.1% H: 0.31% C: -0.63%
BMRN | $91.2 -0.93% -0.89% 1.3M |

Health Technology

| -15.63% | O: 0.25% H: 1.43% C: 1.17%
bioscience growth

---

Gilead Sciences to Release Fourth Quarter & Full Year 2022 Financial Results on Thursday, February 2, 2023
Published: 2023-01-19 (Crawled : 23:00) - biospace.com/
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -19.89% | O: 0.51% H: 0.49% C: -0.65%
sciences year financial results

---

Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published: 2023-01-19 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 12.16% | O: 0.69% H: 0.0% C: -1.52%
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -3.37% | O: 1.26% H: 1.19% C: 1.19%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -18.03% | O: -0.31% H: 1.15% C: 0.68%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| -9.73% | O: 0.13% H: 0.65% C: 0.51%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 6.72% | O: -0.1% H: 0.31% C: 0.17%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -12.74% | O: -0.43% H: 1.33% C: 0.3%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 16.11% | O: 0.17% H: 1.36% C: 1.02%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 113.69% | O: 0.1% H: 0.97% C: -0.37%
BMY | $48.86 -0.27% 1.0% 14M |

Health Technology

| -32.27% | O: 0.29% H: 2.1% C: 1.94%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 12.47% | O: -0.17% H: 1.07% C: -0.16%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -4.65% | O: -0.92% H: 0.0% C: 0.0%
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -19.89% | O: 0.51% H: 0.49% C: -0.65%
AMGN | News | $273.01 -0.19% -0.17% 1.5M |

Health Technology

| 3.26% | O: -0.9% H: 0.58% C: 0.01%
global report growth market

---

Strata Oncology Announces Addition of Gilead as Strata PATH Trial Collaborator
Published: 2023-01-18 (Crawled : 14:20) - prnewswire.com
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -21.46% | O: -0.46% H: 0.12% C: -1.51%
trial

---

Tune Therapeutics Welcomes Noted Industry Leader Dr. John McHutchison to Board of Directors
Published: 2023-01-17 (Crawled : 14:20) - biospace.com/
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -22.24% | O: -0.26% H: 0.37% C: -0.74%
ASMB | $13.48 1.58% 1.56% 5.7K |

Health Technology

| 775.32% | O: 3.25% H: 1.26% C: -1.26%
therapeutics

---

Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published: 2023-01-16 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -5.97% | O: -0.2% H: 0.0% C: 0.0%
PFE | News 4 | $26.27 -0.19% 0.19% 18M |

Health Technology

| -45.1% | O: -2.74% H: 0.43% C: -0.99%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -14.58% | O: 0.33% H: 0.33% C: -0.94%
BMY | $48.86 -0.27% 1.0% 14M |

Health Technology

| -32.62% | O: 0.83% H: 0.52% C: -1.09%
ABT | News | $106.89 -0.65% 0.07% 4.2M |

Health Technology

| -5.83% | O: -0.01% H: 0.69% C: -0.1%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -3.72% | O: 1.1% H: 0.22% C: 0.02%
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -22.24% | O: -0.26% H: 0.37% C: -0.74%
COCP | $1.5559 -0.39% -1.39% 3.9K |

Health Technology

| -27.1% | O: 0.47% H: 11.16% C: 7.91%
hepatitis global antiviral hiv therapeutics growth market

---

Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies
Published: 2023-01-03 (Crawled : 15:00) - biospace.com/
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -21.86% | O: -0.9% H: 1.25% C: 0.36%
collaboration therapeutics

---

Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -2.34% | O: 0.77% H: 0.0% C: -0.74%
AZNCF | News | $135.35 -3.53% -4.19% 400 |

Health Technology

| 0.18% | O: 1.08% H: 0.0% C: -0.25%
PFE | News 4 | $26.27 -0.19% 0.19% 18M |

Health Technology

| -48.82% | O: -0.08% H: 0.21% C: -0.1%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 7.37% | O: -0.01% H: 0.08% C: -0.95%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -16.57% | O: -0.04% H: 0.16% C: -0.47%
BMY | $48.86 -0.27% 1.0% 14M |

Health Technology

| -32.23% | O: 0.04% H: 0.21% C: -0.25%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -2.28% | O: -0.39% H: 0.0% C: 0.0%
GILD | $67.08 0.08% 0.06% 6.2M |

Health Technology

| -21.32% | O: 0.08% H: 0.66% C: 0.61%
EXEL | $23.71 1.8% 1.73% 1.6M |

Health Technology

| 51.4% | O: -0.32% H: 2.91% C: 2.75%
AZN | News | $71.2 0.49% 0.46% 5.4M |

Health Technology

| 4.55% | O: -0.46% H: 0.38% C: 0.01%
global disease report therapeutics cancer market

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4253 179.25% 64.77% 210M |

Consumer Services

BOF | $2.08 77.78% 41.21% 110M |

ILAG | $0.54 12.27% 40.62% 3.7M |

LICN | $0.999 78.39% 40.49% 15M |

AMST | $3.4 70.0% 39.58% 70M |

Technology Services

MTC | $3.6 60.71% 38.04% 9.1M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.458 14.5% 30.92% 91K |

Health Services

WHLM | $6.25 35.87% 28.46% 700K |

Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M |

Information

---

Your saved searches

---